The Journal for ImmunoTherapy of Cancer, an open access, peer-reviewed journal, serves as the global voice of the Society and examines all aspects of tumor immunology and cancer immunotherapy from basic research through clinical application. Learn more.
The Forward Fund is an initiative established by SITC to stimulate the future of the science, development and application of cancer immunology and immunotherapy through financially supporting education and research. Learn more.
For upcoming events and important dates, visit the SITC events calendar.
JITC Digest - June 2016
June 21, 2016
2016 Taubman Prize recipients announced
June 16, 2016
SITC's Final Report from ASCO 2016
June 10, 2016
SITC's Mid-conference Report from ASCO 2016
June 7, 2016
SITC Announces New Collaborative Relationships
May 31, 2016
The SITC Immune Monitor - May 2016
May 26, 2016